-
Product Insights
Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological...